4/A

4/A Filing

Company: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Filed: October 5, 2023
Period of Report: October 2, 2023
Accession Number: 0001493152-23-036424

View Document ↗ View on SEC.gov ↗